Comparative efficacy of combination drug therapy in refractory epilepsy

Neurology

Volumn 78, Issue 1, 2012, Pages 62-68

  Poolos, Nicholas P ^a   Warner, Lindsay N ^a   Humphreys, Sophia Z ^a,b   Williams, Stephen ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fircrest Residential Habilitation Center   (United States)

^c Rainier Residential Habilitation Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE; ANTICONVULSIVE AGENT; TRIAZINE DERIVATIVE;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CENTRAL NERVOUS SYSTEM MALFORMATION; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; EPILEPSY; FEMALE; GENETIC DISORDER; HUMAN; LENNOX GASTAUT SYNDROME; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE; STATISTICAL SIGNIFICANCE; DEVELOPMENTAL DISORDER; DRUG COMBINATION; MIDDLE AGED; TREATMENT OUTCOME;

ANTICONVULSANTS; DEVELOPMENTAL DISABILITIES; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAZINES; VALPROIC ACID;

EID: 84863394524     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31823ed0dd     Document Type: Article

References (20)

1. Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985;313:145-151. (Pubitemid 15047456)
2. Mattson RH, Cramer JA, Collins JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults: The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. N Engl J Med 1992;327:765-771.
3. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1000-1015. (Pubitemid 46436124)
4. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007;369: 1016-1026. (Pubitemid 46436125)
5. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-319. (Pubitemid 30075244)
6. Schiller Y, Najjar Y. Quantifying the response to antiepileptic drugs: effect of past treatment history. Neurology 2008;70:54-65.
7. Deckers CL, Czuczwar SJ, Hekster YA, et al. Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia 2000;41:1364-1374.
8. French JA, Faught E. Rational polytherapy. Epilepsia 2009;50(suppl 8):63-68.
9. French JA. Refractory epilepsy: clinical overview. Epilepsia 2007;48(suppl 1):3-7. (Pubitemid 46280512)
10. Loscher W, Schmidt D. Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma. Epilepsia 2011;52:657-678.
11. Halford JJ, Lapointe M. Clinical perspectives on lacosamide. Epilepsy Curr 2009;9:1-9.
12. Gidal BE, Anderson GD, Rutecki PR, Shaw R, Lanning A. Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy. Epilepsy Res 2000;42:23-31.
13. Huber B, Hauser I, Horstmann V, et al. Long-term course of epilepsy in a large cohort of intellectually disabled patients. Seizure 2007;16:35-42. (Pubitemid 44914589)
14. Steffenburg U, Hedstrom A, Lindroth A, Wiklund LM, Hagberg G, Kyllerman M. Intractable epilepsy in a population-based series of mentally retarded children. Epilepsia 1998;39:767-775. (Pubitemid 28319514)
15. Sunder TR. Meeting the challenge of epilepsy in persons with multiple handicaps. J Child Neurol 1997;12(suppl 1): S38-S43.
16. Choi H, Heiman GA, Munger Clary H, Etienne M, Resor SR, Hauser WA. Seizure remission in adults with longstanding intractable epilepsy: an extended follow-up. Epilepsy Res 2011;93:115-119.
17. Brodie MJ, Yuen AW. Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group. Epilepsy Res 1997;26:423-432. (Pubitemid 27146300)
18. Knoester PD, Keyser A, Renier WO, Egberts AC, Hekster YA, Deckers CL. Effectiveness of lamotrigine in clinical practice: results of a retrospective population-based study. Epilepsy Res 2005;65:93-100. (Pubitemid 41039047)
19. Pisani F, Oteri G, Russo MF, Di Perri R, Perucca E, Richens A. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction. Epilepsia 1999;40:1141-1146. (Pubitemid 29372631)
20. Yuen AW, Land G, Weatherley BC, Peck AW. Sodium valproate acutely inhibits lamotrigine metabolism. Br J Clin Pharmacol 1992;33:511-513.